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Background: Literature on the management of pediatric breast abscess is sparse, therefore
treatment is based on adult literature which describes a shift from incision and drainage (I&D) to
needle aspiration. However, children may not have the same risk factors and may require different
treatment due to concern for damage to the developing breast bud with invasive treatment. We
sought to characterize pediatric breast abscesses and compare outcomes.
Objectives/Goal:
To characterize pediatric breast abscess and determine the optimal initial treatment.

Methods/Design: A retrospective review was conducted of patients with a breast abscess treated
at our institution from January 2008-December 2018. Patients >18 years, those initially treated at
other institutions, those with an actively draining abscess or a post-operative abscess were
excluded. Primary outcome was persistent disease. Secondary outcomes included antibiotic
utilization, number and type of procedures required, and risk factors for abscess and recurrence.
Statistical analysis was performed using STATA® (StataCorp, College Station, TX) and a p-value of
<0.05 determined significance.

Results: Ninety-six patients met inclusion criteria. The median age was 12.8 years [IQR 4.9, 14.3],
81% were female, and 51% were African American. Clinical data is shown in Table 1. Most
commonly, patients were treated with antibiotics alone (47%), followed by I&D (27%), ultrasound
guided aspiration (20%), and blind aspiration alone (6%). Abscess cultures grew predominantly
MRSA in infants and children, and coagulase negative staphylococcus in adolescents (p<0.01).
Twelve patients (13%) had persistent disease. Of these, initial treatment was antibiotic alone in 9
patients, needle aspiration in 2, and I&D in 1 (p=0.35). There was no significant difference in
demographic or clinical characteristics in those with persistent disease compared to those that
responded to initial treatment. Antibiotics alone yielded an 80% success rate in primary treatment.
Conclusions: Initial treatment modality was not associated with persistent disease, thus a trial of
antibiotics alone is warranted to minimize the theoretical risk of breast bud damage with
intervention.
Table 1: Clinical characteristics of pediatric patients with breast abscess

Symptom Duration (days)
Diagnostic Method
US
Physical Exam
Abscess Size (cm)
Treatment
Antibiotics alone
US Aspiration
Blind Aspiration
Incision & Drainage
Antibiotic Used
Clindamycin
Trimethoprim-Sulfamethoxazole
Cephalexin
Mupirocin
None
Culture Results
MRSA
Coagulase negative staphylococcus
Staphylococcus aureus
Gram negative bacteria
No growth
Antibiotic Duration (days)

Frequency or Median
[IQR]
(n=96)
3 [2, 5]
51%
49%
2 [1.5, 2.7]
47%
20%
6%
27%
68%
21%
5%
2%
4%
35%
35%
20%
6%
4%
10 [10, 10]

